Apple will stop selling two of its latest Apple Watches in the U.S. temporarily because of a disagreement over a feature called Blood Oxygen. This decision comes after the U.S. International Trade Commission issued two orders on October 26. These orders limit Apple’s ability to sell products with the Blood Oxygen feature due to a disagreement with Masimo, a medical technology company, according to the report.
For U.S. customers, there won’t be any change in their ability to buy these watches until Thursday. After 3 p.m. on Thursday, online sales of the Apple Watch Series 9 and Apple Watch Ultra 2 will be paused, and in-store sales will stop after Sunday.
Apple Pauses Sales of Watches
The White House had 60 days to review the restrictions, as per ITC policy, or until December 25. However, Apple decided to start the pause early to make sure it follows the order if the ITC ruling remains unchanged.
On Monday, Apple’s stock closed down by less than 1%, while Masimo’s stock gained just over 3%.
If the decision remains in place, one of the ITC’s orders will prevent Apple and its affiliates from importing watches with the Blood Oxygen feature and the materials used for that feature. The second order, a cease and desist, instructs Apple to stop selling products with the Blood Oxygen feature.
If the ITC’s order remains, Apple has stated that it intends to do everything possible to resume the sales of both watches as soon as it can.
People who have already purchased either of the two Apple Watches in question won’t face any problems with their products, according to Apple. Additionally, there are no changes to the availability of these models outside of the U.S.
Apple’s wearables, home, and accessories unit, which includes these watches, is the company’s third-largest source of revenue, bringing in $9.3 billion in the last quarter.
In a statement, Apple expressed strong disagreement with the order and mentioned that the company is exploring various legal and technical options to ensure that the Apple Watch remains accessible to customers.
Masimo, in a statement, remarked that the ITC ruling demonstrates that “even the world’s most powerful company must abide by the law.”
Apple is temporarily halting the sale of two Apple Watches in the U.S. due to a Blood Oxygen feature dispute with Masimo. The U.S. International Trade Commission’s orders prompted this move, impacting Apple’s stock. If the ruling stands, Apple plans to swiftly resume sales, reassuring existing customers and expressing disagreement with the order.